Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The World Health Organization (WHO) and the International Pharmaceutical Federation (FIP) have joined hands to fight against tuberculosis (TB) epidemic.
Subscribe to our email newsletter
Under the deal, both the parties have signed a Joint Statement on the role of pharmacists in tuberculosis care and control.
The agreement aims to increase awareness of TB, and refer people with TB symptoms to facilities with quality diagnosis and treatment.
WHO and FIP focus on patient-centered treatment supervision to promote adherence and help prevent multidrug-resistant TB.
With this contract, they encourage promotion of the rational use of anti-TB medicines through procuring and dispensing quality-assured medicines and fixed-dose combinations recommended by WHO; prohibiting the sale of anti-TB medicines over the counter, or without prescription.
FIP president Michel Buchmann said while recognizing the broader role of pharmacists in the development and use of anti-TB medicines, this Joint Statement focuses on the role of pharmacists directly involved in the care of people with TB.
"The International Pharmaceutical Federation will endeavor to support WHO and their Member States in enabling national tuberculosis programmes and national pharmacy associations to strengthen their collaboration towards care and control of TB and multidrug-resistant-TB globally," Buchmann said.